image
Charles River Laboratories International, Inc. CRL
Healthcare - Medical - Diagnostics & Research - NYSE - US
Watchlist
$ 103.2
-3.19 %
$ 5.07 B
Market Cap
513.35
P/E
Price Target Average
121.66%
Revenue Forecast Estimate
1.89%
EBIT Estimate
30.60%
Net Income Estimate
134.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Charles River Laboratories International, Inc.
image
Wall Street analysts predict an average 1-year price target for CRL of $229 , with forecasts ranging from a low of $151 to a high of $290 .
CRL Lowest Price Target Wall Street Target
151 USD 46.32%
CRL Average Price Target Wall Street Target
229 USD 121.66%
CRL Highest Price Target Wall Street Target
290 USD 181.01%
Price
Max Price Target
Min Price Target
Average Price Target
3003002802802602602402402202202002001801801601601401401201201001008080Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart CRL

image
$4.5b$4.5b$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CRL

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CRL

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029